GSA CAPITAL PARTNERS LLP - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q2 2022$14,000
-97.5%
16,548
-92.4%
0.00%
-97.2%
Q4 2021$563,000
+17.3%
218,338
+108.4%
0.07%
+44.9%
Q3 2021$480,000
-14.7%
104,754
+28.1%
0.05%
-22.2%
Q2 2021$563,000
+323.3%
81,778
+350.5%
0.06%
+186.4%
Q1 2021$133,000
-63.1%
18,151
-59.3%
0.02%
-62.7%
Q4 2020$360,00044,5680.06%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders